News

Consumers are more interested in buying a product they hear great things about. But there’s a hidden downside to all the good vibes.
Bitcoin ( BTC-USD) is expected to rise marginally, 1.1% on a weekly basis, as market sentiments seem to improve on the back ...
CLEVELAND, May 15, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results and business highlights for the first quarter of 2025 and shared recent operational ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.